Literature DB >> 8229052

Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods.

R Kaiser1, C H Lücking.   

Abstract

The sensitivity of six different ELISA techniques and calculation methods for the determination of intrathecal synthesis of IgG antibodies specific to Borrelia burgdorferi was investigated in paired CSF and serum specimens from 33 patients with neuroborreliosis. The diagnostic value of the Antibody Index (AI) was compared with the meaningfulness of serum antibodies to B. burgdorferi (Bb), established by immunofluorescence assay (IFA). The AI, as a standard for intrathecal antibody synthesis was determined from specific antibody ratios (QBb) in the CSF and serum and the CSF/serum ratio of IgG (QIgG) or albumin (QAlb). Using Western blotting with identical concentrations of IgG in the CSF and serum all patients displayed intrathecal synthesis of specific antibodies to at least two B. burgdorferi proteins. The different ELISA methods and calculation procedures were almost equivalent in demonstrating intrathecal synthesis of specific antibodies (32 and 33/33). Calculation of AI from IFA titers was somewhat less sensitive (30/33). In 5 patients titers of serum IgG- and IgM-antibodies to B. burgdorferi determined by IFA were within the normal range or borderline, while elevated AIBb values indicated an autochthonous immune response to B. burgdorferi in the CSF. In uncertain cases of neuroborreliosis calculation of AI from ELISA titers will be useful in clarifying the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8229052     DOI: 10.1016/0022-510x(93)90247-v

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Serodiagnosis of neuroborreliosis: comparison of reliability of three confirmatory assays.

Authors:  R Kaiser; S Rauer
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

2.  Intrathecally produced IgG and IgM antibodies to recombinant VlsE, VlsE peptide, recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis.

Authors:  Gerold Stanek; Lara Lusa; Katarina Ogrinc; Mateusz Markowicz; Franc Strle
Journal:  Med Microbiol Immunol       Date:  2013-12-23       Impact factor: 3.402

Review 3.  [Neuroborreliosis - Diagnostics, treatment and course].

Authors:  R Dersch; S Rauer
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

4.  Acute Flaccid Paralysis: Intravenous Immunoglobulin is Not the Drug of Choice Always!

Authors:  V S V Prasad; Indar Kumar Sharawat; Lokesh Saini; Parag Shankar Rao Dekate; Sampath Penchala; Dandu Ravi Varma
Journal:  Indian J Pediatr       Date:  2018-07-20       Impact factor: 1.967

5.  Intrathecal immune response in patients with neuroborreliosis: specificity of antibodies for neuronal proteins.

Authors:  R Kaiser
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

6.  Misleading presentation of acute Lyme neuroborreliosis.

Authors:  Elizabeth Martha Winter; Philip H Rothbarth; Nathalie M Delfos
Journal:  BMJ Case Rep       Date:  2012-12-06

7.  Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients.

Authors:  R Kaiser
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 8.  [Neuroborreliosis].

Authors:  R Kaiser; V Fingerle
Journal:  Nervenarzt       Date:  2009-10       Impact factor: 1.214

9.  DNA persistence after treatment of Lyme borreliosis.

Authors:  D Pícha; L Moravcová; D Vaňousová; J Hercogová; Z Blechová
Journal:  Folia Microbiol (Praha)       Date:  2013-08-09       Impact factor: 2.099

Review 10.  Limitations and Confusing Aspects of Diagnostic Testing for Neurologic Lyme Disease in the United States.

Authors:  Elitza S Theel; Maria E Aguero-Rosenfeld; Bobbi Pritt; Patricia V Adem; Gary P Wormser
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.